Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

Summary by BizNews.com
ASPI’s Paul Mann accelerates a bold global isotope strategy, linking helium supply with medical isotope demand.

1 Articles

BizNews.comBizNews.com
Lean Right

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

ASPI’s Paul Mann accelerates a bold global isotope strategy, linking helium supply with medical isotope demand.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizNews.com broke the news in on Monday, February 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech icon

Biotech

Australia icon

Australia

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal